Signal 3 determines tolerance versus full activation of naive CD8 T cells: Dissociating proliferation and development of effector function

Journal of Experimental Medicine

Volumn 197, Issue 9, 2003, Pages 1141-1151

  Curtsinger, Julie M ^a   Lins, Debra C ^a   Mescher, Matthew F ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Antigens; Cell division; Immune tolerance; Interleukin 12; Lymphocytes

Indexed keywords

ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12;

ANIMAL CELL; ARTICLE; CELL DIVISION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; EFFECTOR CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SIGNAL TRANSDUCTION;

EID: 0037544148     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021910     Document Type: Article

References (58)

1. Aichele, P., K. Brduscha-Reim, R. Zinkernagel, H. Hengartner, and H. Pircher. 1995. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med. 182: 261-266.
2. Allison, J., I.L. Campbell, G. Morahan, T.E. Mandel, L.C. Harrison, and J.F. Miller. 1988. Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature. 333:529-533.
3. Burkly, L.C., D. Lo, O. Kanagawa, R.L. Brinster, and R.A. Flavell. 1989. T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E. Nature. 342:564-566.
4. Ferber, I., G. Schonrich, J. Schenkel, A. Mellor, G. Hammerling, and B. Arnold. 1994. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science. 263: 674-676.
5. Kyburz, D., P. Aichele, D. Speiser, H. Hengartner, R. Zinkernagel, and H. Pircher. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1956-1962.
6. Morahan, G., J. Allison, and J.F.A.P. Miller. 1989. Tolerance of class I histocompatibility antigens expressed extrathymically. Nature. 339:622-624.
7. Moskophidis, D., F. Lechner, H. Pircher, and R. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature. 362:758-761.
8. Rocha, B., and H. von Boehmer. 1991. Peripheral selection of the T cell repertoire. Science. 251:1225-1228.
9. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63:1249-1256.
10. Wieties, K., R. Hammer, S. Jones-Youngblood, and J. Forman. 1990. Peripheral tolerance in mice expressing a liver-specific class I molecule: inactivation/deletion of a T cell population. Proc. Natl. Acad. Sci. USA. 87:6604-6608.
11. Kirberg, J., L. Bruno, and H. vonBoehmer. 1993. CD4+8-help prevents rapid deletion of CD8+ cells after a transient response to antigen. Eur. J. Immunol. 23:1963-1967.
12. Rocha, B., C. Tanchot, and H. vonBoehmer. 1993. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. Exp. Med. 177:1517-1521.
13. Dubois, P.M., M. Pihlgren, M. Tomkowiak, M. Van Mechelen, and J. Marvel. 1998. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo. J. Immunol. 161:5260-5267.
14. Kearney, E., K. Pape, D. Loh, and M. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity. 1:327-339.
15. + T cells by staphylococcal enterotoxin B. J. Exp. Med. 172:1091-1100.
16. Tanchot, C., S. Guillaume, J. Delon, C. Bourgeois, A. Franzke, A. Sarukhan, A. Trautmann, and B. Rocha. 1998. Modifications of CD8+ T cell function during in vivo memory or tolerance induction. Immunity. 8:581-590.
17. Bevan, M.J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross react in the cytotoxic assay. J. Exp. Med. 143: 1283-1288.
18. Heath, W.R., and F.R. Carbone. 2001. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:47-64.
19. Heath, W.R., and F.R. Carbone. 2001. Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1:126-134.
20. Fazekas de St Groth, B. 1998. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol. Today. 19:448-454.
21. Suss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1789-1796.
22. Mellman, I., and R.M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell. 106: 255-258.
23. Sallusto, F., and A. Lanzavecchia. 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189:611-614.
24. Aderem, A., and R.J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature. 406: 782-787.
25. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
26. Grewal, I., and R. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135.
27. De Smedt, T., B. Pajak, E. Muraille, L. Lespagnard, E. Heinen, P. De Baetselier, J. Urbain, O. Leo, and M. Moser. 1996. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184:1413-1424.
28. Kamath, A.T., J. Pooley, M.A. O'Keeffe, D. Vremec, Y. Zhan, A.M. Lew, A. D'Amico, L. Wu, D.F. Tough, and K. Shortman. 2000. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165:6762-4770.
29. Mueller, D., and M. Jenkins. 1995. Molecular mechanisms underlying function T-cell unresponsiveness. Curr. Opin. Immunol. 7:375-381.
30. Schmidt, C.S., and M.F. Mescher. 2002. Peptide Ag priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12.J. Immunol. 168:5521-5529.
31. Albert, M.L., M. Jegathesan, and R.B. Darnell. 2001. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2:1010-1017.
32. + T cells responding to self-antigens. J. Exp. Med. 196:3.23-333.
33. + T cells. J. Immunol. 162:3256-3262.
34. + T cells in vivo. J. Immunol. 163:2561-2567.
35. - dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:1685-1696.
36. Pooley, J.L., W.R. Heath, and K. Shortman. 2001. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166:5327-5330.
37. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587-592.
38. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63-75.
39. Lauvau, G., S. Vijh, P. Kong, T. Homg, K. Kerksiek, N. Serbina, R.A. Tuma, and E.G. Pamer. 2001. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science. 294:1735-1739.
40. Lee, P.P., C. Yee, P.A. Savage, L. Fong, D. Brockstedt, J.S. Weber, D. Johnson, S. Swetter, J. Thompson, P.D. Greenberg, et al. 1999. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:677-685.
41. + T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. J. Exp. Med. 193:595-605.
42. Zajac, A.J., J.N. Blattman, K. Murali-Krishna, D.J.D. Sourdive, M. Suresh, J.D. Altman, and R. Ahmed. 1999. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.
43. Porgador, A., J.W. Yewdell, Y. Deng, J.R. Bennink, and R.N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity. 6:715-726.
44. Tham, E.L., P.L. Jensen, and M.F. Mescher. 2001. Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins. J. Immunol. Methods. 249: 111-119.
45. Altman, J.D., P.A.H. Moss, P.J.R. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, J.I. Bell, A.J. McMichael, and M.M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:94-96.
46. Busch, D.H., I.M. Pilip, S. Vijh, and E.G. Pamer. 1998. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity. 8:353-362.
47. Daniels, M.A., and S.C. Jameson. 2000. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191: 335-346.
48. Mueller, S.N., C.M. Jones, C.M. Smith, W.R. Heath, and F.R. Carbone. 2002. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195: 651-656.
49. Hogquist, K., S. Jameson, W. Heath, J. Howard, M. Bevan, and F. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76:17-27.
50. Tham, E.L., and M.F. Mescher. 2001. Signaling alterations in activation-induced non-responsive (AINR) CD8 T cells. J. Immunol. 167:2040-2048.
51. Pape, K., E. Kearney, A. Khoruts, A. Mondino, R. Merica, Z. Chen, E. Ingulli, J. White, J. Johnson, and M. Jenkins. 1997. Use of adoptive transfer of T-cell antigen-receptor-transgenic T cell for the study of T-cell activation in vivo. Immunol. Rev. 156:67-78.
52. + T cells in the development of T helper type 1 responses. J. Exp. Med. 195:473-483.
53. Valenzuela, J., C.S. Schmidt, and M.F. Mescher. 2002. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J. Immunol. 169:6842-6849.
54. Vella, A.T., J.E. McCormack, P.S. Linsley, J.W. Kappler, and P. Marrack. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity. 2:261-270.
55. Mitchell, T.C., D. Hildeman, R.M. Kedl, T.K. Teague, B.C. Schaefer, J. White, Y. Zhu, J. Kappler, and P. Marrack. 2001. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat. Immunol. 2:397-402.
56. Oehen, S., and K. Brduscha-Riem. 1998. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161:5338-5346.
57. + T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 194:707-717.
58. + dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196:1099-1104.